GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 24 filers reported holding GAIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,800 | -26.8% | 10,000 | 0.0% | 0.00% | – |
| Q2 2023 | $44,800 | -7.1% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $48,200 | +55.5% | 10,000 | 0.0% | 0.00% | – |
| Q4 2022 | $31,000 | -6.1% | 10,000 | 0.0% | 0.00% | – |
| Q3 2022 | $33,000 | -8.3% | 10,000 | -1.0% | 0.00% | – |
| Q2 2022 | $36,000 | -12.2% | 10,100 | +0.5% | 0.00% | – |
| Q1 2022 | $41,000 | -24.1% | 10,050 | 0.0% | 0.00% | – |
| Q4 2021 | $54,000 | – | 10,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 150,000 | $489,000 | 0.63% |
| CM Management, LLC | 125,000 | $408,000 | 0.46% |
| Greenlight Capital | 546,560 | $1,781,000 | 0.13% |
| Wealth Alliance Advisory Group, LLC | 25,000 | $82,000 | 0.04% |
| Cannell Capital | 12,371 | $40,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $189,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 40,000 | $130,000 | 0.00% |
| HOEY INVESTMENTS, INC | 500 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 87,967 | $286,000 | 0.00% |